You are here
ÈýÒÚÌåÓý¹ÙÍø-Wide Strategic Plan
On this page
About the Strategic Plan
In order to advance its mission and fulfill requirements of the 21st Century Cures Act, ÈýÒÚÌåÓý¹ÙÍø will update its Strategic Plan every 5 years. The most recent iteration, the ÈýÒÚÌåÓý¹ÙÍø-Wide Strategic Plan for Fiscal Years 2021–2025, is an update on the previous plan for fiscal years 2016–2020.
The Strategic Plan outlines ÈýÒÚÌåÓý¹Ù꿉۪s vision for biomedical research direction, capacity, and stewardship, by articulating the highest priorities of ÈýÒÚÌåÓý¹ÙÍø over the next 5 years. In addition, it provides illustrative examples of accomplishments under the last plan and new initiatives under this one. The Strategic Plan was developed through collaboration between leadership and staff across ÈýÒÚÌåÓý¹ÙÍø and key stakeholders, including the research community, professional societies, advocacy groups, and the public.
The ÈýÒÚÌåÓý¹ÙÍø-Wide Strategic Plan is designed to complement and harmonize across ÈýÒÚÌåÓý¹ÙÍø, which address their individual missions
The strategic plan was launched in July 2021 and is being implemented through September 2025. ÈýÒÚÌåÓý¹ÙÍø is currently updating the strategic plan to ensure it is aligned with the current Administration’s priorities and complies with this Administration’s Executive Orders. The updated version will be posted once available.
Strategic Plan Framework
ÈýÒÚÌåÓý¹ÙÍø designed a Framework to inform development of the Strategic Plan. This Framework identifies areas of opportunity that apply across biomedical research and unifying principles to guide ÈýÒÚÌåÓý¹ÙÍø in supporting the biomedical research enterprise. The Framework includes three key Objectives that outline ÈýÒÚÌåÓý¹Ù꿉۪s priorities as aligned with the agency’s goals. Across all of these priorities, ÈýÒÚÌåÓý¹ÙÍø emphasizes several Cross-Cutting Themes—approaches that are common to all Objectives of the Strategic Plan.
Strategic Planning Process
In September 2019, ÈýÒÚÌåÓý¹ÙÍø began updating the ÈýÒÚÌåÓý¹ÙÍø-Wide Strategic Plan to cover fiscal years 2021–2025, adopting a process that was meant to be transparent, focused on science and good stewardship of research, guided by evidence, and informed by ÈýÒÚÌåÓý¹Ù꿉۪s many stakeholders.
The four phases of the strategic planning process included:
Midcourse Review of the Strategic Plan
The Midcourse Review of the ÈýÒÚÌåÓý¹ÙÍø-Wide Strategic Plan for Fiscal Years 2021–2025 is the product of a yearlong process, coordinated by the Division of Program Coordination, Planning, and Strategic Initiatives, that involved working across all 27 ICs and many OD offices to report progress on more than 70 ÈýÒÚÌåÓý¹ÙÍø programs, policies, or processes, during the first 2.5 years of the Plan’s lifecycle. Staff from across the agency engaged in an iterative process to determine which representative activities should be highlighted, and the writeups were drafted by the Institutes, Centers, and OD Offices most heavily involved in each of the activities.
This page last reviewed on March 20, 2025